@article{ATM107242,
author = {Meirong Zhou and Shouman Wang and Nengbin Wan and Songlin Yuan and Xiongqiang Hu and Wei Zhou and Bohua Qing and Mingwen Liu and Weihua Sun and Peizhi Fan and Jianguo Wang and Hong Cao and Haifan Xu and Bin Dai and Peizhi Tang and Liyuan Qian and Xi Zhao and Jun Xiao and Huaiying Zhou and Jinhui Hu and Li Ding and Domenico Tripodi and Nicholas Zdenkowski and Thomas J. O’Keefe and Alejandro Martin Sanchez and Li Chen and Ping Zhang and Feng Xu},
title = {Efficacy and safety of neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy regimen in Chinese patients with HER2-positive early breast cancer: a real-world retrospective multi-center cohort study},
journal = {Annals of Translational Medicine},
volume = {10},
number = {24},
year = {2022},
keywords = {},
abstract = {},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/107242}
}